Biomarker-driven drug development for Allergic Diseases and Asthma-An FDA public workshop. Rabin RL, Altman MC, Arshad SH, Beger RD, et al. J Allergy Clin Immunol 2025 Mar 26:S0091-6749(25)00329.

Read + Share

Amedeo Smart

Independent Medical Education

Rabin RL, Altman MC, Arshad SH, Beger RD, et al. Biomarker-driven drug development for Allergic Diseases and Asthma-An FDA public workshop. J Allergy Clin Immunol 2025 Mar 26:S0091-6749(25)00329.
PMID: 40154576